Are you a patient or caregiver of someone taking Peanut Allergy Oral Immunotherapy (OIT)? Alerje Inc., along with the National Science Foundation (NSF), has a paid, at-home research study that is focused on your daily treatment experience for up to 90 days. We are seeking adults and caregivers of those with a peanut food allergy currently on an FDA-Approved OIT regimen.
OIT Patients, We Need Your Input!
Earn up to $500 to share your insights on a new OIT Management platform funded by the National Science Foundation. The platform’s purpose is to support food allergy patients to reach their ultimate treatment goal: maintenance. Apply today.
Earn a $50 bonus for each qualified person you refer that completes the study. It takes less than 5 minutes a day.
To qualify, you must be:
- An adult currently on FDA-Approved Peanut OIT (i.e., Palforzia) that is 18 or older, OR
- A caregiver of someone currently on FDA-Approved Peanut OIT who is 17 or younger
Make a Difference! Once you complete this study, your insights will inform and improve the lives of OIT patients who are also managing food allergies. Your voice will move the food allergy and oral immunotherapy industries forward.
Must be 18 or older to apply.
Sponsored by Alerje, a Detroit-based Food Allergy Tech Innovation Startup